Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Kreutzfeldt

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
JCO Clinical Cancer Informatics|March 8, 2023
National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer MedicineSimon Kreutzfeldt, Peter Horak, Daniel Hübschmann, et al.
Cells, Tissues, Organs|May 22, 2002
Developmental potential of hematopoietic and neural stem cells: unique or all the same?Nicole Kirchhof, Friedrich Harder, Suzana Petrovic, et al.
Genes, Chromosomes & Cancer|November 22, 2020
Analysis of mutational signatures with yet another package for signature analysisDaniel Hübschmann, Lea Jopp-Saile, Carolin Andresen, et al.
Frontiers in Endocrinology|October 25, 2021
Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare DiseaseSami Matrood, Leonidas Apostolidis, Jörg Schrader, et al.
ESMO Open|December 5, 2019
Community-driven development of a modified progression-free survival ratio for precision oncologyAndreas Mock, Christoph E Heilig, Simon Kreutzfeldt, et al.
BMJ Open Gastroenterology|August 21, 2025
Precision oncology for advanced-stage adenocarcinoma of the appendix: comprehensive molecular characterisation identifies actionable lesions and potential predictive biomarkersSebastian Lange, Hannah Lisiecki, Simon Kreutzfeldt, et al.
Biomolecules|May 28, 2025
Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer TreatmentMaria-Veronica Teleanu, Annika Schneider, Claudia R Ball, et al.
Der Pathologe|May 3, 2021
[Variant interpretation in molecular pathology and oncology : An introduction]Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Der Pathologe|October 4, 2021
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Cold Spring Harbor Molecular Case Studies|August 27, 2020
Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinomaElena Busch, Simon Kreutzfeldt, Abbas Agaimy, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
JCO Clinical Cancer Informatics|March 8, 2023
National Center for Tumor Diseases Precision Oncology Thesaurus for Drugs: A Curated Database for Drugs, Drug Classes, and Drug Targets in Precision Cancer MedicineSimon Kreutzfeldt, Peter Horak, Daniel Hübschmann, et al.
Cells, Tissues, Organs|May 22, 2002
Developmental potential of hematopoietic and neural stem cells: unique or all the same?Nicole Kirchhof, Friedrich Harder, Suzana Petrovic, et al.
Genes, Chromosomes & Cancer|November 22, 2020
Analysis of mutational signatures with yet another package for signature analysisDaniel Hübschmann, Lea Jopp-Saile, Carolin Andresen, et al.
Frontiers in Endocrinology|October 25, 2021
Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare DiseaseSami Matrood, Leonidas Apostolidis, Jörg Schrader, et al.
ESMO Open|December 5, 2019
Community-driven development of a modified progression-free survival ratio for precision oncologyAndreas Mock, Christoph E Heilig, Simon Kreutzfeldt, et al.
BMJ Open Gastroenterology|August 21, 2025
Precision oncology for advanced-stage adenocarcinoma of the appendix: comprehensive molecular characterisation identifies actionable lesions and potential predictive biomarkersSebastian Lange, Hannah Lisiecki, Simon Kreutzfeldt, et al.
Biomolecules|May 28, 2025
Celebrating Ulrik Ringborg: Multi-Omics-Based Patient Stratification for Precision Cancer TreatmentMaria-Veronica Teleanu, Annika Schneider, Claudia R Ball, et al.
Der Pathologe|May 3, 2021
[Variant interpretation in molecular pathology and oncology : An introduction]Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Der Pathologe|October 4, 2021
Peter Horak, Jonas Leichsenring, Simon Kreutzfeldt, et al.
Cold Spring Harbor Molecular Case Studies|August 27, 2020
Successful BRAF/MEK inhibition in a patient with <i>BRAF</i><sup>V600E</sup>-mutated extrapancreatic acinar cell carcinomaElena Busch, Simon Kreutzfeldt, Abbas Agaimy, et al.
Pageof 4